News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
339,407 Results
Type
Article (16704)
Company Profile (81)
Press Release (322614)
Multimedia
Podcasts (15)
Webinars (8)
Section
Business (88605)
Career Advice (521)
Deals (14864)
Drug Delivery (58)
Drug Development (37112)
Employer Resources (46)
FDA (10417)
Job Trends (7090)
News (153343)
Policy (14201)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
Academia (1606)
Accelerated approval (20)
Adcomms (10)
Allergies (114)
Alliances (26930)
ALS (105)
Alzheimer's disease (947)
Antibody-drug conjugate (ADC) (185)
Approvals (10745)
Artificial intelligence (360)
Autoimmune disease (156)
Automation (40)
Bankruptcy (95)
Best Places to Work (6385)
BIOSECURE Act (4)
Biosimilars (88)
Biotechnology (61)
Bladder cancer (109)
Brain cancer (41)
Breast cancer (346)
Cancer (2903)
Cardiovascular disease (216)
Career advice (440)
Career pathing (11)
CAR-T (183)
CDC (9)
Cell therapy (477)
Cervical cancer (24)
Clinical research (32273)
Collaboration (1091)
Compensation (316)
Complete response letters (21)
COVID-19 (1416)
CRISPR (78)
C-suite (445)
Cystic fibrosis (69)
Data (4098)
Decentralized trials (3)
Denatured (10)
Depression (81)
Dermatology (41)
Diabetes (338)
Diagnostics (3652)
Digital health (42)
Diversity (3)
Diversity, equity & inclusion (14)
Drug discovery (154)
Drug pricing (73)
Drug shortages (8)
Duchenne muscular dystrophy (130)
Earnings (35071)
Editorial (17)
Employer branding (1)
Employer resources (42)
Events (47569)
Executive appointments (476)
FDA (12557)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (9)
Frontotemporal dementia (19)
Funding (826)
Gene editing (160)
Generative AI (29)
Gene therapy (402)
GLP-1 (401)
Government (2086)
Grass and pollen (5)
Guidances (234)
Healthcare (10532)
HIV (34)
Huntington's disease (21)
IgA nephropathy (49)
Immunology and inflammation (133)
Immuno-oncology (41)
Indications (90)
Infectious disease (1571)
Inflammatory bowel disease (101)
Inflation Reduction Act (8)
Influenza (63)
Intellectual property (157)
Interviews (62)
IPO (6678)
IRA (16)
Job creations (950)
Job search strategy (374)
JPM (19)
Kidney cancer (9)
Labor market (9)
Layoffs (118)
Leadership (9)
Legal (2330)
Liver cancer (57)
Longevity (18)
Lung cancer (383)
Lymphoma (270)
Machine learning (28)
Management (19)
Manufacturing (505)
MASH (84)
Medical device (10402)
Medtech (10454)
Mergers & acquisitions (8798)
Metabolic disorders (673)
mRNA (89)
Multiple sclerosis (130)
NASH (9)
Neurodegenerative disease (219)
Neuropsychiatric disorders (42)
Neuroscience (1754)
Neurotech (1)
NextGen: Class of 2026 (3481)
Non-profit (2044)
Now hiring (15)
Obesity (230)
Opinion (134)
Ovarian cancer (111)
Pain (155)
Pancreatic cancer (136)
Parkinson's disease (182)
Partnered (19)
Patents (332)
Patient recruitment (334)
Peanut (46)
People (24936)
Pharmaceutical (16)
Pharmacy benefit managers (20)
Phase 1 (10399)
Phase 2 (13967)
Phase 3 (10755)
Pipeline (4143)
Policy (94)
Postmarket research (1046)
Preclinical (4497)
Press Release (30)
Prostate cancer (139)
Psychedelics (11)
Radiopharmaceuticals (135)
Rare diseases (503)
Real estate (2327)
Recruiting (18)
Regulatory (12454)
Reports (21)
Research institute (1471)
Resumes & cover letters (96)
Rett syndrome (25)
RNA editing (7)
RSV (43)
Schizophrenia (85)
Series A (134)
Series B (110)
Service/supplier (4)
Sickle cell disease (49)
Special edition (4)
Spinal muscular atrophy (71)
Sponsored (29)
Startups (1672)
State (1)
Stomach cancer (7)
Supply chain (61)
Tariffs (13)
The Weekly (5)
Vaccines (530)
Venture capital (39)
Weight loss (129)
Women's health (56)
Worklife (3)
Date
Last 7 days (338)
Last 30 days (1350)
Last 365 days (15317)
2026 (4118)
2025 (15483)
2024 (17946)
2023 (20376)
2022 (27514)
2021 (29436)
2020 (28458)
2019 (24268)
2018 (18169)
2017 (16317)
2016 (15237)
2015 (17651)
2014 (12786)
2013 (10542)
2012 (11571)
2011 (12048)
2010 (10551)
Location
Africa (315)
Alabama (50)
Alaska (4)
Arizona (199)
Arkansas (11)
Asia (18402)
Australia (2946)
California (5811)
Canada (1560)
China (597)
Colorado (273)
Connecticut (271)
Delaware (201)
Europe (43219)
Florida (1054)
Georgia (238)
Hawaii (3)
Idaho (37)
Illinois (463)
India (49)
Indiana (333)
Iowa (13)
Japan (269)
Kansas (100)
Kentucky (24)
Louisiana (23)
Maine (23)
Maryland (767)
Massachusetts (4306)
Michigan (208)
Minnesota (418)
Mississippi (5)
Missouri (98)
Montana (26)
Nebraska (13)
Nevada (70)
New Hampshire (55)
New Jersey (1941)
New Mexico (18)
New York (1848)
North Carolina (678)
North Dakota (6)
Northern California (2822)
Ohio (195)
Oklahoma (12)
Oregon (24)
Pennsylvania (1134)
Puerto Rico (14)
Rhode Island (28)
South America (429)
South Carolina (44)
South Dakota (1)
Southern California (2301)
Tennessee (102)
Texas (1048)
United States (22307)
Utah (209)
Vermont (1)
Virginia (155)
Washington D.C. (21)
Washington State (516)
West Virginia (2)
Wisconsin (59)
339,407 Results for "lifestyle delivery systems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
Gilead Keeps Dealing With $300M OncoNano Drug Delivery Cancer Pact
OncoNano’s platform, called ON-BOARD, packages drugs in pH-sensitive micelles that ensure their specific delivery near tumors, while also preventing systemic exposure.
January 6, 2026
·
1 min read
·
Tristan Manalac
IN PARTNERSHIP WITH PII
Hit Me With Your Best Shot: Understanding Autoinjectors and Combination Drug Delivery Systems
In this episode presented by PII, BioSpace’s head of insights discusses with guests Oliver Eden and Travis Webb how autoinjectors offer opportunities to improve delivery systems, patient compliance and clinical trial processes.
October 2, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
April 2, 2026
·
4 min read
Press Releases
Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray
March 16, 2026
·
4 min read
Press Releases
Brazilian Tuberculosis Research Network to Evaluate PharmaJet® Needle-free Tropis® ID Injection Device as Delivery System for Tuberculin Skin Test
March 24, 2026
·
4 min read
Press Releases
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System
January 30, 2026
·
3 min read
Press Releases
SonoThera Presents New Preclinical Data at MDA 2026 Highlighting RIPPLE™ as an Efficient, Scalable, Nonviral Platform for Full-Length Dystrophin Delivery in DMD
· RIPPLE™ (Remote Induction of Pulsed Pressure Lateral to Energy) is a proprietary ultrasound-mediated delivery technology. · RIPPLE™ has been developed to enable efficient, redosable, targeted, and safe delivery of a diverse range of genetic medicines with broad tissue biodistribution, including skeletal, cardiac, and diaphragm muscles.
March 5, 2026
·
1 min read
Press Releases
Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray
March 20, 2026
·
4 min read
Press Releases
Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma
January 1, 2026
·
5 min read
Press Releases
TriSalus Life Sciences Announces Publication Demonstrating Enhanced Delivery and Immune Activation with Nelitolimod Delivered with Pressure-Enabled Drug Delivery in Liver Tumor Models
March 18, 2026
·
8 min read
1 of 33,941
Next
